Multiple System Atrophy Market is driven by rising disease prevalence

σε πρόσθεσε στο Health

2025-05-29 08:27:13 -

Multiple System Atrophy (MSA) therapies encompass neuroprotective agents, symptomatic treatments, and emerging disease-modifying candidates designed to address autonomic dysfunction and parkinsonian features. These interventions offer advantages such as improved motor control, reduced orthostatic hypotension, and enhanced quality of life. Growing emphasis on early diagnosis and personalized...

0 Σχόλια 0 Μοιράστηκε 91 Views 0 Προεπισκόπηση